While RA and TNF-alpha inhibitors have historically been associated with an increased risk of lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is infrequently seen. This evidence concerns the gene TNF and rheumatoid arthritis.